To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Platelet-Rich Plasma vs. Placebo for Achilles Tendon Rupture: 2 Year Outcomes

Download
Share
Reprints
Cite This
About
+ Favorites
Download
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
January 2023

Platelet-Rich Plasma vs. Placebo for Achilles Tendon Rupture: 2 Year Outcomes

Vol: 303| Issue: 1| Number:12| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Platelet-rich plasma injection for acute Achilles tendon rupture : two-year follow-up of the PATH-2 randomized, placebo-controlled, superiority trial

Bone Joint J. 2022 Nov;104-B(11):1256-1265.

Contributing Authors:
DJ Keene J Alsousou P Harrison HM O'Connor S Wagland SJ Dutton P Hulley SE Lamb K Willett PATH-2 Trial Group

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

182/230 patients from the PATH-2 trial responded to this 2-year follow-up study of the PATH-2 trial comparing platelet-rich plasma (PRP; n=88/114) and placebo (92/116). The outcomes of interest included the Achilles Tendon Rupture Score (ATRS), the Patient-Specific Functional Scale (PSFS), and the Short-Form 12 (SF-12) mental and physical component quality of life scores. The results of this study...

Join the Conversation

Please Login or Join to leave comments.